| 中文名 | 4-羧基-2-[(1R)-1-[[2-[(2,5-二氯苯甲酰基)氨基]乙酰基]氨基]-3-甲基丁基]-6-氧代-1,3,2-二氧硼杂环己-4-乙酸 |
|---|---|
| 英文名 | 4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid |
| 中文别名 |
艾沙佐米杂质3
MLN9708游离态 艾沙唑咪 柠檬酸艾莎佐米 伊沙佐米杂质9 柠檬酸伊沙佐米(MLN9708) 埃沙佐米柠檬酸盐 MLN9708, 20S蛋白酶体抑制剂 MLN9708 5mg试剂 MLN9708 10mM * 1mL in DMSO试剂 柠檬酸艾沙佐米 埃沙左米柠檬酸 蛋白酶抑制剂(MLN9708) 艾沙佐米杂质5 |
| 英文别名 |
1,3,2-Dioxaborinane-4-acetic acid, 4-cboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo
4-Cboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid MLN9708;MLN-9708 MLN-9708 analog Ninlo) 4-(cboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-cboxylic acid 4-(cboxymethyl)-2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-cboxylic acid MLN9708,MLN-9708,MLN 4-(Cboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dio MLN9708 20S proteasome inhibitor MLN9708, 10 mM in DMSO cc-436 MLN 9708 analog UNII:E8R04MBQ04 4-(Carboxymethyl)-2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid S2181_Selleck MLN9708 analogues MLN 9708 - Ixazomib citrate 4-Cboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid MLN9708 Esazomide citrate Ixazomib Citrate (MLN9708) Analogue Ixazomib Citrate |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 分子式 | C20H23BCl2N2O9 |
| 分子量 | 517.122 |
| 精确质量 | 516.087341 |
| PSA | 175.31000 |
| LogP | 3.37810 |
| 折射率 | 1.580 |
| 储存条件 | 室温,干燥,密封 |
|
~95%
1201902-80-8 |
| 文献:MILLENNIUM PHARMACEUTICALS, INC. Patent: WO2009/154737 A1, 2009 ; Location in patent: Page/Page column 63 ; |
| 上游产品 2 | |
|---|---|
| 下游产品 0 | |